반응식
[CH3:1][C:2]1[CH:7]=[CH:6][C:5]([N:8]2[CH2:13][CH2:12][NH:11][CH2:10][CH2:9]2)=[CH:4][CH:3]=1.[C:14]1([C:22]2[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=2)[CH:19]=[CH:18][CH:17]=[C:16]([CH:20]=O)[CH:15]=1.[BH-](OC(C)=O)(OC(C)=O)OC(C)=O.[Na+].C1(C2C=CC=CC=2)C=CC=CC=1CN1CCN(C2C=CC=CC=2)CC1>>[C:14]1([C:22]2[CH:23]=[CH:24][CH:25]=[CH:26][CH:27]=2)[CH:19]=[CH:18][CH:17]=[C:16]([CH2:20][N:11]2[CH2:12][CH2:13][N:8]([C:5]3[CH:4]=[CH:3][C:2]([CH3:1])=[CH:7][CH:6]=3)[CH2:9][CH2:10]2)[CH:15]=1참가 물질
5
실험 절차
54.3 mg of the target compound (0.16 mmol, 36.4%) was obtained using 1-(4-methylphenyl)piperazine (154.8 mg, 0.88 mmol), biphenyl-3-carbaldehyde (80 mg, 0.44 mmol) and NaBH(OAc)3 (283.8 mg, 1.32 mmol) according to the synthesis method of Compound 1.
출처 및 근거
- ORD 기록
- ord-8e9ec2bca65b488db4450b75b1f5f896
- 출처 데이터셋
- uspto-grants-2014_11
- 특허 번호
- US08883796B2
연결된 노트
불러오는 중…